SeekingAlpha  Jul 7  Comment 
By Small Pharma Analyst: Ligand Pharmaceuticals (LGND) has been the subject of 3 extremely negative articles in Seeking Alpha over the past month by the same author, Amvona. Not only is this author short on this stock, he/she predicts the company...
SeekingAlpha  Jul 3  Comment 
By Gregory M. Lemelson: Overview Despite a significant downward correction in the share price of Ligand Pharmaceuticals (LGND) since the June 16,2014 publication of its original research report on LGND, Lemelson Capital Management has...
StreetInsider.com  Jun 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ligand+Pharma+%28LGND%29+Affirms+Start+of+Eltrombopag+%2B+Azacitidine+Phase+3+in+MDS/9611994.html for the full story.
Motley Fool  Jun 24  Comment 
TG Therapeutics shares jump after announcing a licensing deal. Find out if this deal makes as much sense as today's pop would imply.
StreetInsider.com  Jun 23  Comment 
The following is a list of notable articles to help get you through the lunch hour: Microsoft (MSFT) Announces Increased Storage, Lower Pricing for OneDrive -> Read this! Roth Capital Comments on New SERM Lasofoxifene Phase 1 Data (LGND) ->...
StreetInsider.com  Jun 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ligand+Pharma+%28LGND%29+Reports+Positive+Data+from+Lasofoxifene+Phase+1/9603789.html for the full story.
Benzinga  Jun 17  Comment 
Shares of Ligand Pharmaceuticals (NASDAQ: LGND) are down again following the results of the Phase III trial of Promacta. GSK Releases Promacta Phase III Results In a press release from June 13, GlaxoSmithKline announced the results from the...
SeekingAlpha  Jun 16  Comment 
By Gregory M. Lemelson: A PDF version of Lemelson Capital's full 25-page report is available here. Lemelson Capital is short shares of Ligand Pharmaceuticals (NASDAQ:LGND), a biotechnology Company with a business model focused on developing or...
StreetInsider.com  Jun 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ligand+Pharma+%28LGND%29+Issues+Positive+Update+on++LGD-6972+Phase+1+in+T2D/9584363.html for the full story.

You may also be interested in articles related to Ligand Pharmaceuticals (LGND):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki